gamma-carboline has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachurin, SO; Bronovitsky, EV; Buchman, VL; Deikin, AV; Elyakov, AB; Ermolkevich, TG; Fedorov, EN; Goldman, IL; Khritankova, IV; Kukharsky, MS; Ovchinnikov, RK; Roman, AY; Sadchikova, ER; Ustyugov, AA | 1 |
1 other study(ies) available for gamma-carboline and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Gamma-carboline inhibits neurodegenerative processes in a transgenic model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Carbolines; Disease Models, Animal; Male; Mice; Mice, Transgenic; RNA-Binding Protein FUS; Survival Analysis | 2015 |